3.2 Meta-analysis for the prevalence of NOAF in COVID-19 infection:
The overall pooled prevalence of NOAF in patients with COVID-19 across multiple studies was 7.8%, with a 95% confidence interval (CI) ranging from 6.54% to 9.32%. (Figure 2)